Related Experiment Videos
Sub-total oesophagectomy with 2 field lymphadenectomy
1Northern Oesophago-Gastric Cancer Unit, Royal Victoria Infirmary, Newcastle upon Tyne, UK. S.M.Griffin@ncl.ac.uk
Minerva Chirurgica
|February 20, 2003
Summary
Surgical resection offers the best chance for long-term survival in esophageal cancer, but cure rates remain stagnant. Identifying patients with short survival times is crucial to avoid aggressive treatments.
Area of Science:
- Oncology
- Surgical Oncology
- Gastroenterology
Background:
- Surgical resection is the only curative option for esophageal cancer, with decreasing risks over two decades.
- Despite surgical advances, cure rates for squamous cell carcinoma and adenocarcinoma of the esophagus have not significantly improved.
- Early-stage esophageal cancer confined to the esophageal wall shows a better prognosis than advanced tumors.
Purpose of the Study:
- To evaluate the effectiveness of sub-total esophagectomy with two-field lymph node dissection for esophageal cancer.
- To identify prognostic factors for short survival in esophageal cancer patients.
- To determine if patients with limited survival can be spared aggressive curative or palliative interventions.
Main Methods:
- Review of surgical outcomes for esophageal cancer patients.
- Analysis of recurrence and survival rates following sub-total esophagectomy with two-field lymph node dissection.
- Prognostic factor analysis to identify patients with poor survival.
Main Results:
- Sub-total esophagectomy with two-field lymph node dissection reduces anastomotic and loco-regional recurrence and improves survival.
- The majority of esophageal cancer patients still succumb to the disease despite aggressive treatment.
- Early-stage disease confined to the esophageal wall has a favorable prognosis with radical surgery.
Conclusions:
- While surgical resection improves survival for esophageal cancer, significant challenges remain in improving cure rates.
- Further research is needed to identify patients unlikely to benefit from aggressive treatment, allowing for tailored palliative care.
- Optimizing treatment strategies based on prognostic indicators is essential for improving outcomes in esophageal cancer.